The March 2026 MedPAC Report to Congress does not single out durable medical equipment (DME) providers specifically. Yet for stakeholders across the DME value chain—suppliers, manufacturers, investors, and strategic partners—the report is one of the clearest signposts of where Medicare policy, spending pressure, and care delivery are heading.